Urinary NGAL-Positive Acute Kidney Injury and Poor Long-term Outcomes in Hospitalized Patients

Kidney International Reports

Volumn 1, Issue 3, 2016, Pages 114-124

  Singer, Eugenia ^a,b   Schrezenmeier, Eva V ^a,b   Elger, Antje ^b   Seelow, Evelyn R ^a   Krannich, Alexander ^a   Luft, Friedrich C ^a   Schmidt Ott, Kai M ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

acute kidney injury; long term outcomes; neutrophil gelatinase associated lipocalin (NGAL)

Indexed keywords

EID: 84996520526     PISSN: 24680249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ekir.2016.07.003     Document Type: Article

References (79)

1. 1 Nash, K., Hafeez, A., Hou, S., Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002), 930–936.
2. 2 Tóth, R., Breuer, T., Cserép, Z., et al. Acute kidney injury is associated with higher morbidity and resource utilization in pediatric patients undergoing heart surgery. Ann Thorac Surg 93 (2012), 1984–1990.
3. 3 Chertow, G.M., Levy, E.M., Hammermeister, K.E., et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104 (1998), 343–348.
4. 4 Ishani, A., Xue, J.L., Himmelfarb, J., et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20 (2009), 223–228.
5. 5 Wald, R., Quinn, R.R., Adhikari, N.K., et al. Risk of chronic dialysis and death following acute kidney injury. Am J Med 125 (2012), 585–593.
6. 6 Wald, R., Quinn, R.R., Luo, J., et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302 (2009), 1179–1185.
7. 7 Bellomo, R., Ronco, C., Kellum, J.A., et al. Acute renal failure─definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 (2004), R204–R212.
8. 8 Chertow, G.M., Burdick, E., Honour, M., et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005), 3365–3370.
9. 9 Gruberg, L., Mintz, G.S., Mehran, R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000), 1542–1548.
10. 10 Levy, M.M., Macias, W.L., Vincent, J.-L., et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33 (2005), 2194–2201.
11. 11 McCullough, P.A., Soman, S.S., Contrast-induced nephropathy. Crit Care Clin 21 (2005), 261–280.
12. 12 Praught, M.L., Shlipak, M.G., Are small changes in serum creatinine an important risk factor?. Curr Opin Nephrol Hypertens 14 (2005), 265–270.
13. 13 Mehta, R.L., Kellum, J.A., Shah, S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 11, 2007, R31.
14. 14 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2 (2012), 1–138.
15. 15 Cruz, D.N., Bolgan, I., Perazella, M.A., et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE criteria. Clin J Am Soc Nephrol 2 (2007), 418–425.
16. 16 Uchino, S., Bellomo, R., Goldsmith, D., et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 34 (2006), 1913–1917.
17. 17 Siew, E.D., Ware, L.B., Gebretsadik, T., et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 20 (2009), 1823–1832.
18. 18 Adiyanti, S.S., Loho, T., Acute kidney injury (AKI) biomarker. Acta Med Indones 44 (2012), 246–255.
19. 19 Edelstein, C.L., Biomarkers of acute kidney injury. Adv Chron Kidney Dis 15 (2008), 222–234.
20. 20 Zeng, X.-F., Li, J.-M., Tan, Y., et al. Performance of urinary NGAL and L-FABP in predicting acute kidney injury and subsequent renal recovery: a cohort study based on major surgeries. Clin Chem Lab Med 52 (2014), 671–678.
21. 21 Nickolas, T.L., Schmidt-Ott, K.M., Canetta, P., et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 59 (2012), 246–255.
22. 22 Di Somma, S., Magrini, L., De Berardinis, B., et al. Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department. Crit Care, 17, 2013, R29.
23. 23 Ronco, C., Legrand, M., Goldstein, S.L., et al. Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective. Blood Purif 37 (2014), 271–285.
24. 24 McCullough, P.A., Shaw, A.D., Haase, M., et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative consensus conference. Contrib Nephrol 182 (2013), 13–29.
25. 25 Murray, P.T., Mehta, R.L., Shaw, A., et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int 85 (2014), 513–521.
26. 26 Zappitelli, M., Washburn, K.K., Arikan, A.A., et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care, 11, 2007, R84.
27. 27 Wheeler, D.S., Devarajan, P., Ma, Q., et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 36 (2008), 1297–1303.
28. 28 Cruz, D.N., de Cal, M., Garzotto, F., et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 36 (2010), 444–451.
29. 29 de Geus, H.R.H., Bakker, J., Lesaffre, E.M.E.H., et al. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 183 (2011), 907–914.
30. 30 Pickering, J.W., Endre, Z.H., The clinical utility of plasma neutrophil gelatinase-associated lipocalin in acute kidney injury. Blood Purif 35 (2013), 295–302.
31. 31 Bagshaw, S.M., Bennett, M., Haase, M., et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 36 (2010), 452–461.
32. 32 Kim, H., Hur, M., Cruz, D.N., et al. Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis. Clin Biochem 46 (2013), 1414–1418.
33. 33 Bachorzewska-Gajewska, H., Malyszko, J., Sitniewska, E., et al. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 26 (2006), 287–292.
34. 34 Hirsch, R., Dent, C., Pfriem, H., et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22 (2007), 2089–2095.
35. 35 Mishra, J., Dent, C., Tarabishi, R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005), 1231–1238.
36. 36 Dent, C.L., Ma, Q., Dastrala, S., et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care, 11, 2007, R127.
37. 37 Bennett, M., Dent, C.L., Ma, Q., et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 3 (2008), 665–673.
38. 38 Perry, T.E., Muehlschlegel, J.D., Liu, K.-Y., et al. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg 110 (2010), 1541–1547.
39. 39 Parikh, C.R., Coca, S.G., Thiessen-Philbrook, H., et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22 (2011), 1748–1757.
40. 40 Haase-Fielitz, A., Bellomo, R., Devarajan, P., et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery─a prospective cohort study. Crit Care Med 37 (2009), 553–560.
41. 41 Koyner, J.L., Vaidya, V.S., Bennett, M.R., et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5 (2010), 2154–2165.
42. 42 Nickolas, T.L., O'Rourke, M.J., Yang, J., et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148 (2008), 810–819.
43. 43 Kümpers, P., Hafer, C., Lukasz, A., et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care, 14, 2010, R9.
44. 44 Yang, H.N., Boo, C.S., Kim, M.-G., et al. Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury. Am J Nephrol 31 (2010), 501–509.
45. 45 Doi, K., Negishi, K., Ishizu, T., et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 39 (2011), 2464–2469.
46. 46 Singer, E., Elger, A., Elitok, S., et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int 80 (2011), 405–414.
47. 47 Grenier, F.C., Ali, S., Syed, H., et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin. Biochem 43 (2010), 615–620.
48. 48 Kume, K., Yasuoka, Y., Adachi, H., et al. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiovasc Revasc Med 14 (2013), 253–257.
49. 49 Ralib, A.M., Pickering, J.W., Shaw, G.M., et al. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 23 (2012), 322–333.
50. 50 Coca, S.G., Garg, A.X., Thiessen-Philbrook, H., et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol 25 (2014), 1063–1071.
51. 51 Srisawat, N., Murugan, R., Lee, M., et al. Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int 80 (2011), 545–552.
52. 52 Srisawat, N., Wen, X., Lee, M., et al. Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol 6 (2011), 1815–1823.
53. 53 Gungor, G., Ataseven, H., Demir, A., et al. Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study. Liver Int 34 (2014), 49–57.
54. 54 Cho, E., Kim, S.-C., Kim, M.-G., et al. The incidence and risk factors of acute kidney injury after hepatobiliary surgery: a prospective observational study. BMC Nephrol, 15, 2014, 169.
55. 55 Fufaa, G.D., Weil, E.J., Nelson, R.G., et al. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia, 2014.
56. 56 Damman, K., Masson, S., Hillege, H.L., et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 32 (2011), 2705–2712.
57. 57 Bolignano, D., Basile, G., Parisi, P., et al. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenat Res 12 (2009), 7–14.
58. 58 Palazzuoli, A., Ruocco, G., Beltrami, M., et al. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Acute Card Care 16 (2014), 93–101.
59. 59 van Deursen, V.M., Damman, K., Voors, A.A., et al. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. Circ Heart Fail 7 (2014), 35–42.
60. 60 Lindberg, S., Pedersen, S.H., Mogelvang, R., et al. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 60 (2012), 339–345.
61. 61 Bachorzewska-Gajewska, H., Tomaszuk-Kazberuk, A., Jarocka, I., et al. Does neutrophil gelatinase-asociated lipocalin have prognostic value in patients with stable angina undergoing elective PCI? A 3-year follow-up study. Kidney Blood Press Res 37 (2013), 280–285.
62. 62 Kuitunen, A., Vento, A., Suojaranta-Ylinen, R., et al. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 81 (2006), 542–546.
63. 63 Watkins, S.C., Williamson, K., Davidson, M., et al. Long-term mortality associated with acute kidney injury in children following congenital cardiac surgery. Paediatr Anaesth 24 (2014), 919–926.
64. 64 Lopez-Delgado, J.C., Esteve, F., Torrado, H., et al. Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification. Crit Care, 17, 2013, R293.
65. 65 Hsieh, M.-J., Chen, Y.-C., Chen, C.-C., et al. Renal dysfunction on admission, worsening renal function, and severity of acute kidney injury predict 2-year mortality in patients with acute myocardial infarction. Circ J 77 (2013), 217–223.
66. 66 Ali, T., Khan, I., Simpson, W., et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 18 (2007), 1292–1298.
67. 67 Morgan, C.J., Zappitelli, M., Robertson, C.M.T., et al. Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J Pediatr 162 (2013), 120–127.e1.
68. 68 Uchino, S., Bellomo, R., Bagshaw, S.M., et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 25 (2010), 1833–1839.
69. 69 Wu, V.-C., Huang, T.-M., Lai, C.-F., et al. Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int 80 (2011), 1222–1230.
70. 70 Chawla, L.S., Acute kidney injury leading to chronic kidney disease and long-term outcomes of acute kidney injury: the best opportunity to mitigate acute kidney injury?. Contrib Nephrol 174 (2011), 182–190.
71. 71 Macedo, E., Zanetta, D.M.T., Abdulkader, R.C.R.M., Long-term follow-up of patients after acute kidney injury: patterns of renal functional recovery. PLoS One, 7, 2012, e36388.
72. 72 Lewington, S., Clarke, R., Qizilbash, N., et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002), 1903–1913.
73. 73 Adler, A.I., Stratton, I.M., Neil, H.A., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321 (2000), 412–419.
74. 74 Papademetriou, V., Lovato, L., Doumas, M., et al. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int, 2014.
75. 75 Koren, M.J., Davidson, M.H., Wilson, D.J., et al. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. Am J Kidney Dis 53 (2009), 741–750.
76. 76 Colhoun, H.M., Betteridge, D.J., Durrington, P.N., et al. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). Am J Kidney Dis 54 (2009), 810–819.
77. 77 Shepherd, J., Kastelein, J.J.P., Bittner, V., et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol 2 (2007), 1131–1139.
78. 78 Tonelli, M., Moyé, L., Sacks, F.M., et al. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med 138 (2003), 98–104.
79. 79 Shepherd, J., Kastelein, J.J.P., Bittner, V., et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol 51 (2008), 1448–1454.